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1. Introduction 
 
1.1. Imaging the immune system 
 
1.1.1. Microscopic morphological and functional investigation of immune cells and tissues. 
In all animal organisms, defense against pathogens and maintenance of tissue integrity are granted 
by a compartment of highly specialized sentinel cells that together form the immune system. These 
cells, termed leukocytes, circulate in the blood and eventually station at peripheral sites, such as 
lymph nodes, spleen, mucosae and skin, where they sense the presence of invading microbes and  
capture danger signals derived from damaged host tissues1. Following inflammatory insults, immune 
cells can exit these compartments and infiltrate the parenchyma of injured organs, for example the 
ischemic and necrotic regions of the heart after a myocardial infarction (MI)2. In the course of chronic 
inflammation, as in the case of cardiovascular disease3 and many forms of tumors4, B and T 
lymphocytes can also gather around the inflamed tissue and form organized structures, known as 
tertiary lymphoid organs (TLOs), where they mount a local long-standing adaptive response. 
The first consistent evidences of leukocyte activation and killing of pathogens were achieved by the 
1908 Nobel Laureates Elie Metchnikoff and Paul Ehrlich who, between the second half of the XIX 
and the beginning of the XX century, discovered the innate and adaptive branches of the immune 
system and described their cellular and humoral components5. In their experimental work, they 
pioneered the application of light microscopes and chemical cell-affine dyes  to study the dynamic 
behavior of immune cells during inflammatory responses6 and to specifically stain different classes 
of immune cells in frozen tissue sections7. Thanks to these techniques, they could identify 
macrophages and “microphages” (later re-named neutrophils) with phagocytic activity8, 9, discover 
tissue-resident mast cells  and classify different granulocyte subtypes7, as well as describe 
phagocyte extravasation and recruitment to inflammatory sites6.   
Thus, elemental microscopy and histochemistry offered a unique contribution to the advent of  
modern immunology. Since Metchnikoff’s and Ehrlich’s work, our knowledge of different immune cell 
phenotypes, developmental pathways and functions under both physiological and pathological 
conditions has vastly expanded. However, microscopy has become only one of several tools that 
are nowadays used to study leukocyte plasticity and fate. In fact, most recent findings in the 
immunological field mainly rely on non-imaging methodologies, including multi-parametric and 
single-cell flow cytometry10, 11, transcriptomics12 and genetic fate mapping13. Although exceptionally 
powerful, these technologies lack the capacity to gather spatial information about inter-cellular 
relationships and interaction with the surrounding environment, which are essential aspects to 
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consider for a full understanding of immunological processes. Thus, microscopy still remains a 
pivotal means of investigation and is currently undergoing a new era of popularity, also prompted by 
major technological breakthrough in optics, molecular chemistry and biology and sample 
preparation14. On the one hand, methodologies and protocols for simultaneous labeling of multiple 
cell subsets have reached a high level of sophistication. The era of immunofluorescence started in 
the 1940-50s, with the development of fluorescently labeled antibodies directed against cell type-
specific surface markers15, 16; many of these were then enlisted in the “cluster of differentiation” (CD) 
nomenclature protocol established in 1982 to universally immunophenotype leukocytes17. 
Nowadays, a range of various fluorescent molecules (fluorophores) with different spectral 
characteristics, intensity and stability can be covalently attached to both polyclonal and monoclonal 
antibodies, and combined into a variety of multicolor staining panels, ad hoc designed to readily 
pinpoint myeloid cells and lymphocytes inside tissues sections and whole organs. In addition, the 
development of numerous fluorescent dyes to target subcellular compartments in living cells18 has 
enabled real-time imaging of in vitro cultured cells, viable explanted organs, or even in vivo 
applications. Moreover, reporter animal models (mostly mice) expressing fluorescent proteins and 
tags under the control of selected genes, have become increasingly sophisticated, allowing to 
selectively track the migration of immune cell subtypes under a variety of different stimuli in vivo19, 
20, 21, 22. In parallel with the development of novel labeling strategies, the microscopy hardware has 
strongly evolved, enabling multicolor and multidimensional imaging with improved quality. 
Fluorescent widefield microscopes became used instruments in research laboratories between the 
1970s and 1980s23, when they allowed to perform bidimensional multi-color imaging of thin 
histological sections of hematopoietic and lymphatic organs24, 25. However, the quality of such 
images, which suffered from poor lateral resolution and  out-of-focus fluorescence haze, was 
insufficient for the level of cellular and subcellular detail required to investigate immune responses 
in detail. A revolutionary improvement was the introduction of the first confocal microscope in 195526, 
27. Confocal laser-scanning microscopy (CLSM) consents to generate high resolution three-
dimensional (3D) images, obtained by means of point-by-point scanning of highly focused laser 
sources on the sample. Elimination of out-of-focus fluorescence is achieved with a light-shielding 
filter, the pinhole, which is positioned at optimal distance from the focal plane of the objective lens. 
As a consequence, a collection of images solely consisting of in-focus information, can be stacked 
by shifting the focus along the z dimension. The final result is a high-quality multidimensional 
representation of complex sample architectures28.  
Nowadays, CLSM is still the “golden standard” for investigation of immune cell localization, activation 
and recruitment. However, imaging of many immunological events in situ can be challenging, since 
most tissues and organs measure several hundreds of μm in thickness when explanted for ex vivo 
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investigation and are located deeply in the body for in vivo imaging. Widefield and confocal 
microscopies do not provide the sufficient level of depth penetration and subcellular resolution, which 
is required for accurate visualization and analysis of such locations. Both modalities are typically 
limited to a maximum imaging depth of 50-80 μm inside a sample because ultraviolet (UV) and visible 
light is rapidly absorbed and scattered by tissues, irremediably compromising both lateral and axial 
resolution28.  
 
 
1.1.2. Two-photon microscopy: principles and applications in immunology.   
In 1931 Maria Göppert-Mayer first theorized the phenomenon of two-photon absorption as an 
alternative way to bring a molecule to its excited state29. Based on her work, the first two-photon 
laser scanning microscope (TPLSM) was patented in 199030. In TPLSM (also referred to as 
multiphoton microscopy) fluorochromes are excited within 10-18 s by two near-infrared (NIR) photons 
of ideally half the energy (wavelengths between 760 nm and 1200 nm) of the light normally required 
for linear single-photon excitation (figure 1A). Since the two-photon absorption spectra of most 
fluorochromes are rather broad, spanning over several hundreds of nm, two-photon microscopes 
are capable to excite various fluorescent molecules in the same sample simultaneously with just one 
wavelength. This is a noticeable advantage in terms of speed when performing multi-color imaging 
experiments in real time. Because long NIR wavelengths can penetrate deeper and up to a couple 
of mm in transparent tissues, most organs can be imaged in situ after minimal surgical exposure, 
granting high-resolution images at depths which are not accessible with conventional CLSM. In 
addition, the low energy carried by NIR photons consents to repeatedly scan the same volume with 
high frequency, yet causing only marginal photobleaching and photodamage when compared to 
single-photon excitation. Furthermore, because two-photon excitation is a non-linear phenomenon, 
the probability of a fluorochrome to be excited quadratically depends on the intensity (so the amount 
of photons) of the excitation pulse. Therefore two different photons need to be absorbed by the same 
fluorophore virtually at once, a rare event that can occur only in proximity of  the focal plane of the 
objective lens that converges the exciting laser light (figure 1B). Consequently, optical sectioning of 
a sample is achieved without the presence of a pinhole, as for CLSM, since only one focal plane at 
a time is illuminated. This results in further reduction of light-induced bleaching and damage in the 
surrounding regions of the sample31. 
 
Introduction 
 
4 
 
Figure 1: Principle and advantages of two-photon excitation. 
(A) Jablonski diagrams comparing single-photon (as in CLSM) and two-photon excitation. In TPLSM, the energy carried 
by two nearly simultaneous photons of low-energy NIR light acts in an additive fashion and causes the fluorescence 
emission of fluorochromes. (B) Schematic representation of the excited volume (green region) in a 3D sample in CLSM 
(left) and TPLSM (right). In TPLSM only fluorochromes in the focal plane are reached by sufficiently high density of photons 
so that they can reach the excited state and emit fluorescence. Thus TPLSM allows to perform “confocal” imaging without 
the implementation of a pinhole. (C) Comparison among widefield microscopy, CLSM and TPLSM with regard to lateral 
and axial resolution, depth penetration, generation of label-free information, simultaneous acquisition of multiple 
fluorescent channels and capacity to separate overlapping emission spectra. TPLSM offers the best compromise among 
all characteristics; it is particularly advantageous for visualizing thick and deep-located tissues, at high resolution while 
collecting both label-derived and label-free fluorescence.   
 
An additional technological advance of TPLSM imaging is that it permits the observation of several 
biological structures in a label-free setting. In fact, the majority of autofluorescent biological 
molecules also possess a two-photon excitation spectrum and can be excited in this modality32. In 
addition, non-centrosymmetric molecules, like fibrillar collagens (type I, II, III, V and XI) and elastin, 
that constitute the extra-cellular matrix of many mammalian tissues, have the characteristic of 
scattering light photons with precise geometric angles thanks to the periodicity of their aminoacidic 
chains. As a result, two scattered NIR photons can recombine into one with exactly half the 
wavelength (so with double energy), a physical phenomenon known as “second harmonic 
generation” (SHG)33(figure 2A). By collecting the newly produced “blue” photons in a dedicated 
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detection channel, it is possible to visualize, among others, bone tissue, collagen capsules and the 
adventitial tunica of big vessels in a label-free fashion (figure 2B). Hence, the combination of 
exogenous targeted labelling combined with both autofluorescence and SHG adds significant 
morphological information facilitating spatial orientation and reconstruction of complex tissue 
architecture. 
 
 
Figure 2: Label-free imaging of tissues through intrinsic SHG. 
(A) Representation of the SHG principle. Two-photon excitation of non-centrosymmetric structures, like some tissue 
collagens, results in the scattering and recombination of the NIR-photon pair into a single photon with twice the energy (ω) 
and half the wavelength (λ) used to excite the sample. Detection of this SHG signal contributes to the formation of a label-
free image of the generating tissue. (B) Examples of collagen bundles deposited in different types of tissues from various 
species and visualized via SHG. Images in panel B are reprinted from34; no permission required. 
 
Altogether, TPLSM offers unique technical features that allow spatiotemporal and functional 
investigation of processes in both innate and adaptive immunity. Its applications have so far included 
measuring the migratory behavior of circulating neutrophils19 and monocytes35 during infection or 
sterile inflammation, portraying anti-tumoral and anti-metastatic activity36, 37, 38 of different leukocyte 
subtypes and studying lymphocyte and dendritic cell (DC) interplay inside activated lymphoid 
organs39. In addition, TPLSM imaging is a relevant tool to image immune cell production40, release 
from and homing back to41 the bone marrow (BM) both ex vivo and in vivo. Continuous 
methodological improvements will further contribute to its attractiveness, making it a state-of-the-art 
tool for the realization of increasingly complex immunological studies. 
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1.2. Visualizing immune cell production 
 
1.2.1. Hematopoiesis 
A research field that greatly benefited from the technical advances of fluorescent microscopy is the 
study of hematopoiesis, i.e. the developmental process which leads to the production and 
differentiation of blood and immune cells42. The currently accepted model of hematopoiesis 
establishes that undifferentiated pluripotent hematopoietic stem cells, which reside in the yolk sac 
and liver during embryonic and fetal life, and in the BM after birth, give rise to lineage-restricted 
progenitors which, in turn, differentiate into erythrocytes, platelets and all leukocytes43 (figure 3). 
Together with their differentiation activity, hematopoietic stem cells (HSCs) are also characterized 
by the ability to self-renew, for maintaining themselves throughout the whole life on an individual44. 
By contrast, HSC-derived multipotent progenitors (MPPs) and other downstream progenitors 
progressively show higher degree of commitment and decreased self-renewal capabilities. Such 
progression, which continuously replenishes the different hematopoietic compartments in the steady 
state, is strictly regulated by both hematopoietic stem and progenitor cell (HSPC)-intrinsic and -
extrinsic factors45. Moreover, it becomes highly modulable during physiological aging46, as well as in 
the course of inflammation, infections and malignancies47. In addition, it constitutes the foundation 
of therapeutic BM transplantation for the cure of some genetic immune-deficiencies and 
hematopoietic neoplasia48. Thus, it is of crucial importance to understand the cellular and molecular 
cues driving HSPC behavior. 
Figure 3: The hematopoietic system 
in the steady-state 
Representation of hematopoiesis 
according to the most recent single-cell 
analysis studies, which have highlighted 
the presence of several pre-committed 
subsets within the commonly known 
progenitors and precursors (indicated by 
the squares). Few HSCs constitute the 
vertex of the whole system, while lineage 
differentiation already starts with 
subpopulations of MPPs, each more 
committed to give rise to a specific 
progeny. Perturbations of general 
hematopoietic balance progressively 
occur during individual’s ageing or in the 
course of acute and chronic pathological 
events. Reprinted from49 with permission 
from Elsevier.    
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1.2.2. The hematopoietic niche: insights from BM imaging studies 
Thanks to recent imaging studies, it has become particularly evident that hematopoiesis is a highly 
spatially-regulated phenomenon. That is, the balance between HSC quiescence and activation is 
maintained (or altered) mainly in response to cellular and molecular cues in their immediate vicinity, 
a specialized microenvironment known as the “hematopoietic niche” 50. Although the niche concept 
dates back to 1978 51, when it was initially proposed, insights into its components and complexity 
have rapidly increased in the past decade. In fact, identification of real HSCs in the BM (hence the 
possibility to put them in relation to other cells and structures) in the past was mostly hampered by 
lack of specific markers and required complex panels of surface molecules not easily translatable to 
microscopy. In 2005, the SLAM family51 of markers was proposed, that allowed to discriminate cells 
almost exclusively enriched in HSC activity as to be CD48- CD150+ 52. This discovery greatly 
facilitated successful visualization of antibody-labeled HSCs with only two colors. Moreover, due to 
RNA sequencing and single-cell analysis, some other genes have by now been identified which are 
(almost) exclusively expressed by HSCs at high level, consenting the creation of different fluorescent 
reporter mouse lines (table 1). 
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Table 1: Reporter mice for HSC/HSPC identification 
List of reporter mice developed for specific identification of HSCs and HSPCs. Note that the majority of models have 
already been utilized for optical microscopic applications. Reprinted by permission from Springer Nature53.    
 
The combination of these newly developed labeling strategies with advanced in situ deep 
fluorescence microscopy (CLSM and TPLSM), in some cases also benefiting from more or less 
sophisticated sample-clearing methods54, 55, has finally allowed to gather important, although still 
preliminary, information regarding HSC interaction with multiple niche components. In this regard, a 
pivotal role is played by BM stromal cells, described with different names and markers (for instance 
CXCL12 abundant reticular (CAR) cells56, also defined as leptin receptor (LEPR)+ cells57). They are 
the major source of BM-derived CXCL12 and stem cell factor (SCF), the two most important 
regulators of HSPC maintenance and retention, by acting on HSPC-expressed receptors CXCR458 
and KIT59, respectively. Several recent studies have shown that HSCs establish close contacts also 
with the endothelial cells of BM blood vessels, sinusoids and arterioles. Indeed, the great majority of 
HSCs is found in perisinusoidal regions, in a quiescent and hypoxic state52, 54, 60. However, a minor 
fraction (about 10%) of HSCs are also localized in proximity of arterioles and some other studies 
have pointed out the role of peri-arteriolar nestin (Nes)+61 and neural/glial antigen 2 (NG-2)+62 cells 
in the maintenance of the niche. Even if the respective contribution of sinusoids and arterioles and 
their perivascular cells is still a matter of debate, it is nonetheless clear that the hematopoietic niche 
is primarily a vascular niche. In support of this, the direct role of endothelial cells (both arteriolar and 
sinusoidal) on HSCs has also been investigated and mechanistic evidences of their involvement in 
HSCs biology has been proved63, with special contribution of the endothelial Notch-derived signals64. 
Nevertheless, several evidences derived from additional imaging experimental models, have also 
pinpointed the importance of other cells of both hematopoietic and non-hematopoietic origins, 
including megakaryocytes65, T regulatorary (Treg) lymphocytes66, adipocytes67, osteoblasts68 and 
sympathetic neurons69 whose fibers run alongside BM arterioles (figure 4). At present the exact role 
of each of these actors still remains controversial, as they have been shown to affect HSC biology 
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in sometimes contrasting ways, depending on the model and experimental settings, in some cases 
promoting HSC expansion and, in some others, leading to their exhaustion54, 57, 70. Moreover, 
important regulators of either HSCs or the aforementioned niche players also include long-distance 
signals such as secreted granulocyte-colony stimulating factor (G-CSF), a potent inducer of HSC 
release from the BM and myeloid cell production71, 72. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4: Identified components of the hematopoietic niche 
Schematic depiction of the main niche cell types. To some of them, contrasting roles and regulatory functions on the activity 
of HSCs have been attributed in different studies and models. With the exception of osteo-lineage cells, for which a role in 
the maintenance of HSC viability and self-renewal had initially been proposed (now restricted solely to maintenance of the 
lymphoid lineage73), all other niche cells locate in proximity of central BM sinusoids and arterioles. Hematopoiesis is thus 
believed to be a vasculature-associated process. Reprinted by permission from Springer Nature50.    
 
It has been recently shown that the major contribution to the various hematopoietic lineages in the 
steady state is derived from the active proliferation of more differentiated progenitors74, 75, while 
HSCs mostly rest in an inactive state and get activated only after major BM insults76, 77, 78. 
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Unfortunately, to date little effort has been made to image hematopoietic progenitor cells down-
stream of HSCs79, although recent work has characterized the in situ step-wise production of 
subpopulations of leukocytes, namely neutrophils, under both healthy and inflammatory conditions80. 
However many questions regarding physiological and pathological production of other specific 
hematopoietic subsets still await to be answered.  
 
1.3. Investigating monocyte development and activity 
 
1.3.1. Developmental and phenotypical aspects of monocytes 
In healthy individuals, monocytes arise from HSCs in the fetal liver and in the BM during embryonic 
and adult hematopoiesis, respectively. Production in the spleen has also been observed in mice in 
the course of inflammatory responses81. In BM, the earliest CD115+ monocyte-committed progenitor 
described is the monocyte and dendritic cell progenitor (MDP)82, 83, which derives from the common 
myeloid progenitor (CMP) and/or the granulocyte monocyte progenitor (GMP)84 (although their 
existence as a homogeneous entity has been recently questioned in both mice85 and humans86). 
MDPs are characterized by high expression of KIT/CD117 and FLT3/CD135, and low expression of 
Ly6C. In vivo, these cells can generate both cDCs and monocytes. In particular, they give rise to a 
CD115 (CSFR1)+ monocyte-restricted progenitor called common monocyte progenitor (cMoP)87, 
which differs from MDPs for its lack of FLT3 expression while being Ly6C+. cMoPs have long been 
considered direct precursors of mature monocytes. However, a BM-resident population of immature  
monocytes has been recently described and named “transitional pre-monocytes” (TpMos)88. These 
cells permanently reside in the BM due to high expression of the chemokine receptor CXCR4 (which 
characterizes all BM-resident hematopoietic cells) and constitute a readily-available source of 
monocytes which proliferate and are mobilized upon downregulation of CXCR4 in response to 
inflammatory stimuli. In summary, some myeloid-committed early progenitors sequentially 
differentiate into MDPs, cMoPs and TpMos prior to generating mature monocytes (figure 3). 
In both mice89 and humans90 circulating and BM monocytes comprise two main distinct subsets, 
known as classical and nonclassical monocytes (CMs and NCMs). In flow cytometry analysis, CMs 
and NCMs in mice are distinguished on the basis of the membrane expression of Ly6C, with CMs 
being Ly6Chigh and NCMs being Ly6Clow. Monocytes characterized by intermediate expression of 
Ly6C are considered to be a transitional developmental stage between CMs and NCMs and are 
called intermediate monocytes (IMs)91. In addition, CMs harbor high levels of the chemokine receptor 
CCR2, and moderate amounts of the chemokine receptor CX3CR1. Conversely, NCMs are CCR2-
negative, while expressing the highest levels of CX3CR1. In human blood, CMs and NCMs maintain 
the same dichotomy as observed in mice with regard to CCR2 and CX3CR1 expression92, but are 
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otherwise distinguishable on the basis of the differential levels of the Fc-receptors CD14 and CD16. 
In particular, human CMs are CD14high CD16- CCR2high CX3CR1+, whereas human NCMs are 
CD14low CD16+ CCR2low CX3CR1high. Furthermore, transitional IMs are characterized as CD14+ 
CD16+. Hence, mouse CMs and NCMs share several phenotypical, as well as functional, aspects 
with human CMs and NCMs so that both subsets can be generally related between the two species. 
However, gene expression profiling of human and mouse monocytes also indicated that a number 
of differences exist and that some genetic programs of a particular subset are species-specific92. A 
major difference between the two species is the respective subset ratio in the blood of healthy mice 
or humans, respectively. While CMs and NCMs are equally distributed in the mouse circulation, 
about 80% of human monocytes are CMs, with the remaining 20% being further shared between 
IMs and NCMs, possibly reflecting species-specific variations in the control of monocyte production 
rate, life-span and clearance. Indeed, based on pulse-labeling and fate-mapping experiments, it has 
been calculated that human circulating NCMs survive for approximately 7 days93, whereas their half-
life is only 2 days in mice, although it can be extended depending on the environmental conditions94.  
In the experimental setting of in vitro colony forming assays, MDPs have been shown to produce 
both circulating CMs and NCMs, albeit with different kinetics. As an in vivo confirmation, adoptively 
transplanted MDPs and cMoPs gave rise to CMs within 1 to 4 days after transfer, and to NCMs 
between 3 and 6 days, in PB, BM and spleen87. These results suggested that either MDPs (and 
MDP-derived cMoPs) were in fact a heterogeneous mixture of different CM- and NCM-biased 
precursors, or that NCMs constituted a more terminally differentiated stage of monocyte 
development, following CMs. Fate-mapping tracing and single-cell transcriptomic analysis of 
monocyte subsets successively revealed that indeed CMs can convert into NCMs94, while transiently 
giving rise also to IMs, and that this process is strongly dependent on the expression and activity of 
the transcription factors C/EBP-B and NR4A1, since both Cebpb- and Nr4a1-deficient mice lack 
NCMs from their circulation91, 95, 96. Although these studies have concluded that monocyte conversion 
is a blood-borne phenomenon, other investigations provided convincing evidence that CMs can turn 
into NCMs also in the BM and spleen97, 98. Specifically in the spleen, NCM production has been linked 
to a Notch-2-dependent mechanism triggered by Dll1 (a Notch ligand) expression on splenic 
sinusoids95. However, the mechanism regulating monocyte conversion in the BM has not been 
investigated so far.  
 
1.3.2. Monocyte functions in health and disease 
For decades circulating monocytes have been regarded exclusively as a transitional developmental 
state between immature BM precursors and activated tissue macrophages. However, the discovery 
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of multiple monocyte subsets together with the advent of more sophisticated investigative tools 
contributed to substantially revise the role of monocytes under both healthy and inflammatory 
conditions, uncovering new and complex aspects of monocyte behavior as well as re-assigning to 
monocytes functional characteristics, which were previously believed to exclusively belong to 
macrophages and cDCs49 (figure 5).  
CMs are also commonly known as “inflammatory” monocytes since they used to, and partially still 
do, represent a paradigm for flow-dependent circulating cells which roll on and adhere to activated 
endothelial surfaces at sites of inflammation in response to soluble cytokines secreted by injured 
parenchymal cells, endothelial cells, other leukocytes and platelets; thereafter, they transmigrate into 
inflamed tissues following chemokine gradients that mainly involve their surface receptors CCR2, 
CCR5 and CX3CR199, 100. Once entering the inflammatory milieu, CMs can undergo various destinies 
depending on the specific environmental conditions of the infiltrated tissue/organ, the microbial 
status and the secretion of pro- versus anti-inflammatory mediators from by-standing immune and 
stromal cells. While it is still true that CMs can develop into bona fide macrophages and cDCs by 
fully activating distinctive genetic programs, it is now becoming clear that they can also maintain a 
monocytic status and only acquire some functional characteristics and markers (up-regulation of 
Cd11c and MHC-II) that make them act and phenotypically resemble tissue phagocytes. In either 
case, CMs exhibit a wide range of plasticity, performing numerous pro-inflammatory tasks which 
span from pathogen killing and cytotoxicity, antigen presentation, T cell priming to anti-inflammatory 
and reparative pro-fibrotic and pro-angiogenic functions49. 
Alternatively, steady-state CMs can also turn into NCMs, which have been first described over a 
decade ago as blood-resident leukocytes that crawl on the luminal surface of microcirculatory blood 
vessels in a flow-independent fashion in search of endothelial damage cues101, 102, 103. This ability to 
monitor the healthy status of the microvasculature has gained them the definition of “patrolling” or 
“sentinel” monocytes. From a molecular point of view, NCMs peculiar motility relies on the integrins 
LFA1 and VLA4, but not on CX3CR1. Moreover, NCMs can sense specific pathogen-/danger-
associated molecular patterns (PAMPs and DAMPs) that activate TLR7, and respond by secreting 
neutrophil-attracting mediators to promote neutrophil recruitment to the site of injury, where they also 
contribute to the disposal of cell debris after pathogen clearance. More recently, NCMs have been 
observed in the lumen of big early atherosclerotic arteries of ApoE-deficient mice, where their 
patrolling behavior was enhanced by diet-induced hypercholesterolemia104. As a consequence, 
depletion of NCMs increased atherosclerotic severity and plaque burden105. A role for NCMs in 
atherosclerosis had been previously proposed in more advanced stages of plaque formation, and 
involved CCR5-dependent recruitment of NCM inside the lesions99. Nevertheless, the capacity of 
NCMs to extravasate and infiltrate tissues remains controversial although demonstrated in some 
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contexts, e.g. in the injured myocardium during the latest inflammatory stages of MI106. Finally, NCMs 
have also been reported to be part of the pro-tumoral milieu in the lung metastatic niche via inhibition 
of the cytotoxic activity of natural killer (NK) cells106. Thus, while several mechanisms of action have 
been proposed for NCMs in both health and disease, many aspects of their biology still remain 
enigmatic, largely due to the lack of an unambiguous methodology to specifically visualize NCMs in 
their physiological environment. 
 
Figure 5: Diversity of monocyte functions 
Schematic representation of monocyte roles and fate in healthy and diseased states. CMs can either function as precursors 
of tissue macrophages and DCs or maintain an essentially distinct genetic program, while exerting tissue-repair and 
antigen-presenting activities. Alternatively, they can give rise to new subtypes of effector monocytes with emergency 
functions or convert in vessel-patrolling NCMs. Reprinted from49 with permission from Elsevier. 
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1.4. Aim of the thesis. 
 
The current thesis presents how in situ TPLSM imaging of hematopoietic cells in their native 
environments can be implemented to unveil novel aspects of their development, interactions and 
function in steady state and inflammation. In particular, the three studies included here aimed to: 
• develop a strategy to label and visualize HSCs in whole-mounted BM in the steady state, in 
mice with different genetic background in order to analyze their mutual spatial relationship 
with other BM-resident cells, namely nucleated erythroid cells (NECs) (study 1); 
• visualize the effects of myocardial infarction (MI) on HSCs in the BM and lymphoid 
populations in fat-associated lymphoid clusters (FALCs) within the pericardial fat (study 2); 
• identify a novel marker to selectivity label and track NCMs in blood and tissues, uncovering 
the spatiotemporal features of physiological monocyte conversion in the BM and the role of 
extra-vascular NCMs in MI-activated FALCs (study 3).
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2. Publications
 
2.1. Publication I 
Duchene J†, Novitzky-Basso I†, Thiriot A*, Casanova-Acebes M*, Bianchini M*4 , Etheridge SL*, 
Hub E*, Nitz K*, Artinger K, Eller K, Caamaño J, Rülicke T, Moss P, Megens RTA, von Andrian UH, 
Hidalgo A, Weber C, Rot A. Atypical chemokine receptor 1 on nucleated erythroid cells regulates 
hematopoiesis. Nat Immunol. 2017 Jul;18(7):753-761. DOI: https://doi.org/10.1038/ni.3763 
 
2.1.1. Regulation of the HSC niche by erythroid cells in the BM. 
Background:  
Nucleated erythroid cells (NECs) are the precursors of circulating erythrocytes and constitute the 
majority of all hematopoietic cells in the BM. However, their contribution to BM homeostasis and in 
particular to hematopoiesis is unknown. The hematopoietic niche is controlled by several molecular 
cues including chemokines and their cognate receptors, of which the best described are CXCL12 
and CXCR4. Cells of the erythroid lineage, along with some blood vessels in the BM, are 
characterized by the expression of ACKR1, an atypical chemokine receptor, which acts as a 
molecular sink and transcellular transporter for more than twenty chemokines. Interestingly, the 
rs2814778(G) polymorphism in the Ackr1 gene leads to the absence of this receptor specifically from 
erythroid cells in individuals of African ancestry, as well as being strongly associated with benign 
neutropenia, although the molecular mechanisms of this phenotype are not yet understood.   
Aim:  
Investigating the role of ACKR1 on NECs as a possible modulator of hematopoiesis.  
Key findings: 
• HSCs and NECs can be visualized in whole-mounted BM as CD150+ Lin- CD48- CD41- and 
CD71+ cells, respectively, based on the expression of these markers on the cell surface.  
• In Ackr1-/- mice, HSCs interact less with NECs and are located at further distances. 
• NECs regulate hematopoiesis via physical interactions with HSCs  depending on ACKR1.
  
 
4 Contribution as co-second author:  
• Implementation of a labeling strategy to visualize HSCs and NECs with TPLSM in whole-mounted BM 
specimens (Supplementary fig. 7 A-B).  
• Measurement of minimal distances between HSCs and NECs in 3D (Supplementary fig. 7C). 
• Quantification of HSC-NEC interactions and comparison between Ackr1+/+ and Ackr1-/- mice (Fig. 6 A-C). 
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2.2. Publication II 
Horckmans M, Bianchini M5, Santovito D, Megens RTA, Springael JY, Negri I, Vacca M, Di Eusanio 
M, Moschetta A, Weber C, Duchene J, Steffens S. Pericardial Adipose Tissue Regulates 
Granulopoiesis, Fibrosis, and Cardiac Function After Myocardial Infarction. Circulation. 2018 Feb 
27;137(9):948-960. DOI: https://doi.org/10.1161/circulationaha.117.028833 
 
2.2.1. Role of pericardial FALCs as regulators of post-MI hematopoiesis and immune 
response. 
Background:  
Cardiac ischemia and infarction result in the massive necrosis of cardiomyocytes with consequential 
impairment of cardiac function and systemic repercussions on the homeostasis of the whole 
organism. Locally, the release of pro-inflammatory mediators from the injured tissue promotes the 
onset of an acute inflammatory response, which eventually initiates post-MI cardiac repair and the 
formation of a fibrotic scar replacing the damaged muscle. Such response involves a massive 
recruitment of inflammatory innate cells during the initial phases of the disease and of B and T 
lymphocytes at later stages. However, recruitment of adaptive immune cells from the circulation is 
also observed within hours after the onset of MI. The epicardial AT in humans and the PAT in mice, 
which are located in proximity of the infarcted area, contain numerous FALCs, arising the hypothesis 
of a potential involvement of FALCs in the immune response to MI.  
Aim:  
Evaluating how MI affects cell dynamics in FALCs and hematopoiesis in the BM. 
Key findings: 
• B and T cells are visualized in whole-mounted PAT by surface expression of the markers 
B220 and CD3, respectively, and are exclusively clustered in FALCs. 
• Both B and T cells substantially expand in FALCs after MI and are more numerous in 
knockout mice with increased basal numbers of peripheral B cells.  
• Pericardial FALC B cell activation is linked to enhanced HSC expansion in the BM, both in 
mice with basally elevated B cell counts as well as in response to MI. 
 
5 Contribution as second co-author: 
• Implementation of B and T cell imaging with TPLSM in whole-mounted PAT in a mouse model of MI (Fig. 2D 
and 4A). 
• Comparative visualization of FALCs between mice with physiological and increased basal B cell burden before 
and after MI (Fig. 2D and 4A).  
• Comparative TPLSM imaging of HSCs in whole-mounted BM specimens between mice with physiological and 
increased basal B cell burden after MI (Fig. 5D and Supplementary fig. 6B).  
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2.3. Publication III 
Bianchini M*6 , Duchêne J*, Santovito D, Schloss MJ, Evrard M, Winkels H, Aslani M, Mohanta SK, 
Horckmans M, Blanchet X, Lacy M, von Hundelshausen P, Atzler D, Habenicht A, Gerdes N, Pelisek 
J, Ng LG, Steffens S, Weber C†, Megens RTA†. PD-L1 expression on nonclassical monocytes 
reveals their origin and immunoregulatory function. Sci Immunol. 2019 Jun 21;4(36).  pii:eaar3054. 
DOI: https://doi.org/10.1126/sciimmunol.aar3054 
 
2.3.1. A NCM marker for imaging studies of monocyte conversion and NCM function. 
Background:  
NCMs are a subset of leukocytes residing in the peripheral circulation, where they crawl on the 
luminal surface of blood vessels to sense early endothelial damage. While reporter Cx3cr1
+/gfp mice 
have been instrumental to initially characterize the patrolling behavior of NCMs, this chemokine 
receptor is expressed by the whole monocyte-macrophage compartment, thus requiring the 
application of a broader panel of markers to distinguish individual cell populations as commonly 
performed in flow cytometry experiments. However, optical fluorescence microscopy relies on a 
more limited number of detection channels, making it particularly challenging to transfer the same 
panels utilized in flow cytometry to imaging technologies. As such, there is a strong need to identify 
a NCM-restricted marker for discrimination of these cells in complex tissues, when simultaneous 
visualization of multiple cell types and structures is demanded.  
Aim:  
Identification, validation and application of a novel positive surface marker for microscopic studies of 
NCM monocyte biology.  
Key findings: 
• Programmed cell death 1 ligand 1 (PD-L1) marks NCMs ex vivo and in vivo in blood and BM 
both under steady-state and inflammatory conditions (MI model). 
• PD-L1- CM-to- PD-L1+ NCM conversion in the BM is associated to a specific vascular niche 
and altered during ageing. 
• After MI, NCMs accumulate in pericardial FALCs where they negatively regulate T cell 
survival via PD-L1.
 
6 Contribution as co-first author: 
• Study design. 
• Flow cytometry validation of PD-L1 expression in blood and BM. 
• Microscopic imaging of NCMs and their environment in blood, BM and PAT in different mouse models. 
• Data quantification, analysis and interpretation. 
• Manuscript writing. 
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3. Summary 
 
TPLSM is a powerful imaging tool to investigate the spatial and temporal aspects of immune cell 
development, organization and functions under a variety of physiological and pathological 
conditions. By generating multicolor images of virtually unaltered tissues with subcellular resolution 
at considerable imaging depths, it provides both architectural and mechanistic insights into 
immunological processes in vivo and ex vivo, thus significantly contributing to the expansion of our 
knowledge of the immune system. This thesis includes three studies in which TPLSM was applied 
to unveil novel features of hematopoiesis and monopoiesis in the BM, as well as to investigate the 
dynamics of activated pericardial FALCs following MI. 
The first study addressed the role of NECs as regulators of HSC differentiation in the BM. NECs are 
the most abundant cells of hematopoietic origin inside the BM and, together with sinusoidal 
endothelial cells, express high levels of the ACKR1, an atypical chemokine receptor which binds 
several inflammatory chemokines without inducing cell migration. The human rs2814778(G) 
polymorphism in the promoter of the Ackr1 gene prevents gene expression in cells of the erythroid 
lineage. This genetic variant is also associated with benign neutropenia in individuals of African 
ancestry, although the molecular basis of such phenotype has so far been unknown. Therefore, the 
aim of this study was to investigate how the genetic deletion of Ackr1 on NECs affects neutrophil 
production and hematopoiesis in general. Ackr1-/- mice displayed different frequencies of HSPCs, 
which also expressed higher levels of neutrophil-associated effector molecules. These changes 
were specifically ascribed to erythroid ACKR1 in the BM, but not to the vascular 
compartment.TPLSM of whole-mounted femoral BM to visualize HSCs and NECs in an unaltered 
3D environment, revealed that ACKR1 promotes direct physical contacts between these two cell 
populations, thereby highlighting a previously unidentified contribution of NECs to the hematopoietic 
niche. The alternative pattern of hematopoiesis that developped in absence of ACKR1 resulted in 
increased expression of effector molecules on mature neutrophils, which are more prone to leave 
the circulation and accumulate in spleen, thus causing neutropenia.  
The second study investigated the function of pericardial FALCs as coordinators of post-MI 
hematopoiesis and immune response. FALCs are tertiary lymphoid structures present in the adipose 
tissues and particularly abundant in the PAT, where they sense danger signals derived from the 
infarcted tissue. TPLSM of whole mounted PAT in mice 3 days after induction of MI showed local 
increment of both B and T cells specifically inside FALCs, in response to pro-inflammatory cytokines. 
Such expansion was due to local proliferation of GM-CSF+ B cells and recruitment of T cells through 
CCR7+ DCs. Effects on both DCs and T cell numbers and activation were enhanced in Cb2-/- mice 
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(which present higher basal levels of circulating and peripheral B cells) and abrogated after depletion 
of B cells or blocking of GM-CSF, corroborating the substantial role of B cells in triggering a local 
adaptive immune response in the PAT post-MI. The activation of lymphoid cells within FALCs also 
caused augmented production of G-CSF, a regulator of the hematopoietic niche. Emergency 
hematopoiesis and granulopoiesis, also assessed with TPLSM of whole mounted femurs, caused a 
second wave of neutrophils infiltrating the infarcted heart. Finally, enhanced FALC activation as seen 
in Cb2-/- mice resulted in aggravated fibrosis 7 days post-MI and impaired heart function. 
The third study aimed at discovering and applying a novel marker to specifically visualize and track 
NCMs in circulation and tissue via microscopy. Herein, the immune check-point PD-L1 was identified 
and validated as a membrane marker uniquely expressed by circulating NCMs both ex vivo and in 
vivo, with higher specificity compared to the commonly used CX3CR1. PD-L1 also marked NCMs 
and IMs in the BM. Thus a PD-L1-based multicolor labeling strategy was implemented to quantify 
monocyte subsets and vascular compartments in whole mounted femurs with TPLSM. NCMs and 
IMs were especially enriched  in the epiphysis where their numbers correlated with the extension of 
transition zone (TZ) vessels. Moreover, BM monocytes were distributed within specific vascular 
microdomains, with CMs being in direct contact and more proximal to TZ vessels, while IMs and 
NCMs were increasingly more distant. Time-course analysis of monocyte conversion in situ 
demonstrated that this spatial distribution reflects progressive differentiation of CMs into NCMs, 
potentially triggered by engagement of CMs by TZ vessels. In aged mice, defective conversion was 
indeed associated to loss of TZ vessels. NCMs retained the exclusive expression of PD-L1 among 
blood leukocytes after MI and were found in the extravascular space of pericardial FALCs, as well 
as in human TLOs of atherosclerotic patients. NCMs significantly increased in FALCs 3 days after 
MI, where they actively interacted with T cells and induce their later apoptosis through PD-L1.  
Hence, the studies presented in this thesis applied TPLSM to uncover novel regulators of 
hematopoiesis, both locally during the steady-state (NECs) and remotely during MI-driven 
inflammation (pericardial FALCs). Moreover, due to the application of PD-L1 as a specific NCM 
marker, the development of NCMs in BM could be assigned to a specific vascular niche. Finally, 
TPLSM established a previously unknown PD-L1-dependent immunomodulatory function of NCMs 
inside FALCs after MI.
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4. Zusammenfassung 
 
Die Zwei-Photonen-Laser-Scanning-Mikroskopie ( „Two-photon laser scanning microscopy“, 
TPLSM) ist eine leistungsstarke Technologie, um Immunzellen in ihrer Reifung, Organisation und 
Funktion unter physiologischen oder auch pathophysiologischen Bedingungen zu untersuchen, 
unter Berücksichtigung von räumlichen und zeitlichen Aspekten. Es lassen sich hiermit, mehrfarbige 
Fluoreszenzbilder von nahezu unmodifizierten Präparaten mit einer beachtlichen subzellulären 
Auflösung aufnehmen. Mittels  dieser neuartigen in vivo oder auch ex vivo Analyse lassen sich neue 
mechanistische Erkenntnisse über immunologische Prozesse ableiten, was signifikant zu unserem 
Verständnis über das Immunsystem beiträgt. Die vorliegende Dissertation beinhaltet drei Studien, 
in denen mithilfe der TPLSM neue Charakteristika der Hämatopoese und Monopoese im 
Knochenmark untersucht wurden. Zudem wurde die Dynamik der Aktivierung von Lymphozyten-
Clustern im perikardialen Fettgewebe („fat-associated lymphoid clusters“, FALCs) nach Herzinfarkt 
mittels TPLSM untersucht. 
In der ersten Studie wurde die Rolle der kernhaltigen Erythrozytenvorläufer („nucleated erythroid 
cells“, NECs) als Regulatoren der hämatopoetischen Stammzell (HSC)-Reifung erforscht. Im 
Knochenmark sind NECs der am häufigsten vorhandene hämatopoetische Zelltyp. Gemeinsam mit 
sinusoidalen Endothelzellen weisen NECs eine hohe Expression des atypischen 
Chemokinrezeptors ACKR1 auf. ACKR1 bindet zwar verschiedene inflammatorische Chemokine, 
löst aber keine Zellmigration aus. Der humane Polymorphismus rs2814778(G) im Promotor des 
Ackr1 Gens ist mit einer fehlenden Expression des Chemokin-Rezeptors in Zellen erythroiden 
Ursprungs verbunden. Zudem ist diese genetische Variante mit einer benignen Neutrophilie 
assoziiert und tritt gehäuft in Menschen mit afrikanischer Abstammung auf. Die molekularen 
Grundlagen der Neutrophilie sind bislang jedoch unbekannt. Im Rahmen dieser Studie sollte daher 
untersucht werden, wie die genetische Defizienz von Ackr1 in NECs die Neutrophilen-Produktion 
und die Hämatopoese im Allgemeinen beeinflusst. Die vorliegende Arbeit zeigt, dass Ackr1-
defiziente Mäuse eine veränderte Anzahl an hämatopoetischen Vorläufern aufweisen, die zudem 
durch einen höheren Anteil von neutrophilen Effektor-Molekülen charakterisiert sind. Diese 
Veränderungen sind dem Erythrozyten-ACKR1 zuzuschreiben, während der vaskuläre ACKR1 
dabei keine Rolle spielt. Mittels 3-dimensionaler TPLSM Analyse des femoralen Knochenmarks in 
seiner Gesamtstruktur konnte zudem gezeigt werden, dass ACKR1 direkte Zell-Zell-Kontakte 
zwischen NECs und HSCs vermittelt. Somit wurde eine neue Funktion der NECs innerhalb der 
hämatopoetischen Knochenmarksnische aufgedeckt. Die veränderte Hämatopoese in Abwesenheit 
des ACKR1 resultiert weiterhin in einer vermehrten Bildung von reifen Neutrophilen, welche mit mehr 
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Effektor-Molekülen ausgestattet sind, vermehrt in die Zirkulation mobilisiert werden und sich in der 
Milz ansammeln, was eine Neutrophilie zur Folge hat. 
Die zweite Studie beschäftigte sich mit der Funktion perikardialer FALCs als Koordinatorender 
Hämatopoese und der Immunantwort nach Herzinfarkt. FALCs sind tertiäre lymphoide Strukturen, 
die im adipösen Gewebe lokalisiert sind, insbesondere im perikardialen Fett. Hier nehmen sie 
Gefahr-Signale wahr, die vom infarzierten Areal ausgesandt werden werden. Die TPLSM des 
perikardialen Fettgewebes in seiner Gesamtstruktur 3 Tage nach Induktion des Herzinfarkts ergab 
eine Expansion von B- und T-Zellen innerhalb der FALCs, als Antwort auf erhöhte Spiegel 
proinflammatorischer Zytokine. Es zeigte sich, dass hierbei insbesondere GM-CSF-sezernierende 
B Zellen sowie die CCR7-abhängige Migration von Dendritischen Zellen in die perikardialen FALCs 
eine entscheidende Rolle spielen. Die Effekte auf T Zellen und Dendritische Zellen treten deutlich 
verstärkt in Cb2-defizienten Mäusen mit erhöhten zirkulierenden und peripheren B-Zellzahlen auf 
und lassen sich umgekehrt durch B-Zell-Depletion oder GM-CSF-Blockade hemmen. Diese 
funktionellen Experimente untermauern die essentielle Rolle der B-Zellen als Antreiber der lokalen 
adaptiven Immunantwort im perikardialen Fettgewebe nach Myokardinfarkt. Weiterhin führt die 
Aktivierung der perikardialen FALCs zu erhöhter G-CSF-Produktion und somit der Notfall-
Granulopoese im Knochenmark. Dies wurde anhand von TPSLM des femoralen Knochenmarks in 
seiner Gesamtstruktur dokumentiert. Letztendlich bewirkt die vermehrte Aktivierung des 
perikardialen Fettgewebes in den Cb2-defizienten Mäusen eine vermehrte Fibrose und schlechtere 
Herzfunktion 7 Tage nach Infarkt. 
Ziel der dritten Studie war es, einen neuen Marker für nicht-klassische Monozyten („non-classical 
monocytes“, NCM) zu identifizieren, der eine in vivo Zellmarkierung zur Visualisierung und 
Verfolgung der Zellen in Zirkulation und Gewebe mittels Mikroskopie ermöglicht. Als spezifischer 
Zelloberflächenmarker für NCM wurde der Immuncheckpoint PD-L1 gefunden und sowohl in vivo als 
auch ex vivo validiert. Dabei zeigte sich eine deutlich bessere Spezifität im Vergleich zum 
herkömmlich verwendeten Marker CX3CR1. PD-L1 markiert zudem NCM und intermediäre 
Monozyten (IM) im Knochenmark. Infolgedessen wurde eine mehrfarbige Markierungsstrategie für 
die TPLSM entwickelt, um Monozyten-Subpopulationen im Bezug zu den vaskulären 
Kompartimenten in Gesamtgewebestrukturen des femoralen Knochenmarks zu quantifizieren. Es 
zeigte sich, das NCM und IM vorwiegend im Bereich der Epiphyse anzufinden sind, die reich an 
Transitionszonen (TZ)-Gefäßen ist. Darüber hinaus sind Knochenmarks-Monozyten im Bereich 
spezifischer Gefäß-Mikrodomänen angehäuft. Dabei sind klassische Monozyten („classical 
monocytes“, CM) in direktem Kontakt und eher proximal zu TZ-Gefäßen lokalisiert, wohingegen IM 
und NCM zunehmend weiter entfernt positioniert sind. Die in situ Untersuchung der Monozyten-
Konversion im Zeitverlauf unterstützt die Beobachtung, dass die räumliche Verteilung auf eine 
Zusammenfassung 
 
22 
 
progressive Differenzierung von CM zu NCM zurückzuführen ist. Dabei spielt die Interaktion der CM 
mit den TZ Gefäßen möglicherweise eine direkte Rolle. In gealterten Mäusen geht der Verlust der 
Monozyten-Konversion mit einem Verschwinden der TZ Gefäße einher. Die spezifische Expression 
des Markers PD-L1 bleibt auch nach einem Herzinfarkt stabil und selektiv auf den NCM exprimiert, 
sowohl im Blut als auch im perikardialen Fettgewebe. Auch in humanen tertiären lymphoiden 
Organen in Aortenpräparaten von Patienten mit Atherosklerose waren PD-L1-exprimierende 
Monozyten nachweisbar. Im Hinblick auf eine mögliche funktionelle Rolle im Kontext eines 
Herzinfarkts zeigte sich, dass NCMs innerhalb von 3 Tagen massiv in perikardiale FALCs von 
Infarkt-Mäusen einwandern und dort mit T Zellen interagieren. Diese funktionelle PD-L1-vermittelte 
Interaktion zwischen NCM und T Zellen führt zur Apoptose-Induktion in den T Zellen. 
Zusammenfassend zeigen diese Studien, dass mithilfe der TPLSM neue Regulatoren der 
Hämatopoese identifiziert werden konnten, sowohl homöostatisch (was die Rolle der NECs betrifft) 
als auch unter Herzinfarkt-vermittelter Entzündung (bezüglich perikardialer FALCs). Darüber hinaus 
ermöglichte die Etablierung des NCM Markers PD-L1, dass die NCM Konversion im Knochenmark 
einer spezifischen Gefäßnische zugeordnet werden konnte. Zudem verhalf die TPLSM letztendlich 
zur Aufdeckung einer bislang unbekannten PD-L1-vermittelten immunomodulatorischen Funktion 
der NCM innerhalb perikardialer FALCs im Zusammenhang mit einem Herzinfarkt.
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5.  Perspectives 
 
Understanding how immune cell production is regulated under steady-state conditions and how this 
gets modified during different physiological and pathological states (for example genetic variation, 
aging and inflammation) is of critical importance to further progress our knowledge of immunology. 
Currently known modalities of alternative hematopoiesis, which include emergency47, trained107 and 
clonal108 hematopoiesis, result into the production of immune cell subtypes with different 
phenotypical and behavioral characteristics from what observed under steady-state conditions. 
Detailed comprehension of how HSPCs and their progenies are modulated requires thorough 
characterization of the spatial components of early and later hematopoietic niches. Nowadays this 
is possible thanks to advanced optical imaging methodologies among which TPLSM  stands out for 
informativity and resolution power at considerable imaging depth in a sample.  
In this thesis, evidence is provided that proliferation and differentiation of HSCs in the BM is 
modulated by surrounding NECs, and in particular by the ACKR1 expressed on NEC surface. 
Absence of ACKR1 from this specific cellular compartment, as it occurs in individuals of African 
ancestry, leads to an alternative priming of HSCs, which results into by-passed or accelerated 
differentiation of downstream MPPs, overall myeloid instruction of HSPCs and, ultimately, the 
production of neutrophils with increased effector molecular signatures and extravasation capability. 
Although in situ imaging showed that ACKR1 presence on NECs is unequivocally required for HSC 
scaffolding inside NEC clusters, how exactly cell-cell contacts are mediated by ACKR1 still needs to 
be elucidated. In fact, ACKR1 could act in trans as a molecular anchor for chemokines involved in 
HSC regulation or through hypothetical oligomerization with other chemokine receptors such as 
CXCR4, whose cognate ligand CXCL12 is the main responsible of HSPC retention in the BM, but 
does not directly bind to ACKR1. Alternatively, ACKR1 might engage a non-chemokine partner on 
HSCs, such as CD82109, and directly signal to HSCs. For this, application of advanced imaging 
modalities, such as super-resolution microscopy, could offer valuable insights into the exact 
positioning of ACKR1 and its counterpart(s) within HSC-NEC units. Of notice, NECs form by far the 
most abundant cellular population in the BM, approximately 30-50% of non-stromal cells, while HSCs 
are estimated to be only around 0.007%52. Considering that all NECs express ACKR1, albeit at 
different levels depending on the maturation stage, and that they are rather homogeneously 
distributed throughout bone cavities, it is tempting to suppose that other structural and cellular 
entities contribute to define the exact localization of NECs specifically involved with HSCs. ACKR1 
on NECs may act as a direct or indirect molecular platform for other niche players which in turn 
influence HSC behavior. Thus, visualization of HSC-NEC niches in combination with other known 
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niche components, blood vessels and mesenchymal cells among others, may help to better 
characterize these aspects.  
Aside from being regulated by local cues, BM hematopoietic niches can also respond to danger 
signals originating from distant organs, consequently boosting the development of preferential forms 
of immune cell subtypes, that can also sensibly differ from their steady-state forms, in a process 
overall known as emergency hematopoiesis. Here it is reported that increased systemic G-CSF 
levels in response to MI enhance granulopoiesis, in a mechanism driven by lymphocyte and DC 
activation in pericardial FALCs. Complete removal of PAT, as well as inhibition of various FALC 
components, both demonstrated the centrality of these tertiary lymphatic structures in regulating the 
activation of neutrophil-biased HSPCs. In this regard, microscopy was pivotal to spatially define the 
distinctive expansion of lymphocytes in response to MI in confined, organized cellular units inside 
the adipose tissue, where communication between B, T cells and DCs can be efficiently modulated. 
However, the precise mechanisms by which the infarcted heart drives B cell proliferation and 
proliferation/attraction of DCs and T cells remains to be fully elucidated. To this extent, it would be 
interesting to define the involvement of the vascular blood and lymphatic networks connecting the 
heart and the pericardium to the juxtaposed adipose tissue, by evaluating their post-MI 
morphological remodeling. Likewise, since the sympathetic nervous system plays a fundamental role 
in modulating and synchronizing many aspects of immune cell development and function110, local 
changes in sympathetic innervation might also be involved in FALC activation and should be 
investigated further.  
In addition, other cell types residing in visceral fat deposits (e.g. macrophages, innate lymphoid cells 
and adipocytes themselves) should be examined as well and their relationship with FALC-residing 
lymphocytes and DCs explored.  
In the third study, it is demonstrated that PD-L1+ NCMs readily accumulate specifically in post-MI 
FALCs, where they restrict the expansion of T cells over time by inducing their apoptosis. It is still 
not clear if, in the context of MI, T cell immunomodulation by NCMs also has an impact on FALC-
controlled granulopoiesis, neutrophil recruitment to the heart and tissue repair. However, these 
findings open the way to interesting new concepts about the role played by NCMs in inflammatory 
diseases, on top of the vascular patrolling and neutrophil-attraction activities so far attributed to them. 
The additional identification of PD-L1+ NCMs in human TLOs under chronic inflammatory conditions 
further endorses the hypothesis that immunomodulation by NCMs regulating adaptive immune 
responses inside local TLOs, could play a broader role in chronic pathologies, not limited to 
cardiovascular disease. In this context, it is particularly interesting that immunomodulatory therapies 
targeting PD-L1 are already in clinical use, as in the case of several types of tumors111.   
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NCMs gathering in FALCs after MI were likely recruited from the circulatory pool, as suggested by 
the presence of some of these cells attached to the outer wall of FALC-perfusing vessels. This would 
also be in line with the notion that NCMs infiltrate the injured heart independently of previous 
recruitment of CMs106, which do not convert locally, although in vivo imaging studies using PD-L1 as 
a novel and highly specific tracking tool would be required to fully demonstrate NCM extravasation 
and migration inside the PAT parenchyma. In such a scenario, it would be important to clarify whether 
“immunomodulatory” PD-L1+ NCMs totally overlap with their steady-state patrolling counterparts or 
are de novo generated cells, recruited from the BM during emergency hematopoiesis. In the steady-
state, NCMs originate upon conversion of CMs in the peripheral blood and other hematopoietic 
organs. In this work, application of PD-L1 as an IM- and NCM-marker consented to investigate 
monocyte conversion in situ in the BM, revealing it to be a strictly temporally and spatially regulated 
phenomenon. In particular, the physical engagement of CMs by endosteal TZ vessels was proposed 
as a necessary step for subsequent production of IMs and NCMs. Indeed, aged mice that harbored 
altered TZ vessels were characterized by a dramatic reduction of IMs and NCMs, both in BM and 
blood. However, further TPLSM or nanoscopic characterization of CM-TZ vessel cross-talk is 
required in order to identify the exact molecular determinants responsible for CM priming and how 
this event is possibly modulated under non-physiological conditions. In this regard, over-production 
of NCMs has been observed in the course of some inflammatory pathologies112, 113, 114, hinting at an 
altered conversion process. Moreover, alternative pathways of monopoiesis have also been 
described during infection84 and fibrosis115, involving the activation of non-canonical monocyte 
precursors, suggesting that biological stress could induce other ontogenetic routes of NCM 
production either in addition or in replacement of conversion. TPLSM imaging of monocyte subsets 
in different mouse models of inflammatory disease will help to further elucidate these aspects. The 
novel specific NCM-marker PD-L1 will be central for such studies. 
Taken together, the studies presented in this thesis exemplify three applications of TPLSM for the 
visualization and analysis of immune cell production and interaction in specific physiological and 
pathological contexts, unraveling previously unknown spatial and mechanistic aspects, which will 
constitute the basis for future research on these subjects. 
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